Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea)

Science of the Total Environment

Volumn 408, Issue 3, 2010, Pages 636-643

  Yoon, Yeomin ^a   Ryu, Jaena ^b   Oh, Jeill ^b   Choi, Byeong Gyu ^b   Snyder, Shane A ^c  

^a University of South Carolina   (United States)

^b Chung Ang University   (South Korea)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Endocrine disrupting compounds; Occurrence; Personal care products; Pharmaceuticals; Surface waters; Wastewater treatment plants

Indexed keywords

ATENOLOL; ATMOSPHERIC PRESSURE CHEMICAL IONIZATION; CARBAMAZEPINE; DISSOLVED ORGANIC CARBON; DRINKING WATER; ENDOCRINE DISRUPTING COMPOUND; ETHYNYLESTRADIOL; HAN RIVER; LC-MS/MS; MEAN CONCENTRATIONS; MICROPOLLUTANTS; MUSK KETONE; NAPROXENS; OCCURRENCE; PERSONAL CARE PRODUCTS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; SEOUL , SOUTH KOREA; SOUTH KOREA; STEROID HORMONE; TANDEM MASS SPECTROMETRY; TARGET COMPOUND; ULTRAVIOLET ABSORBANCE; WASTEWATER TREATMENT PLANTS; WATER QUALITY PARAMETERS;

AMIDES; ATMOSPHERIC IONIZATION; ATMOSPHERIC PRESSURE; BIOCHEMICAL OXYGEN DEMAND; CHEMICAL COMPOUNDS; CHROMATOGRAPHIC ANALYSIS; DISSOLUTION; DISSOLVED OXYGEN; EFFLUENTS; ELECTROSPRAY IONIZATION; ENDOCRINOLOGY; HORMONES; IONIZATION; KETONES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ORGANIC CARBON; PARTICLE DETECTORS; POTABLE WATER; RIVERS; SEWAGE PUMPING PLANTS; WASTEWATER; WASTEWATER RECLAMATION; WASTEWATER TREATMENT; WATER QUALITY; WATER RECYCLING; WATER TREATMENT PLANTS;

RIVER POLLUTION;

4,4' ISOPROPYLIDENEDIPHENOL; ATENOLOL; ATORVASTATIN; ATRAZINE; BENZOPHENONE; CAFFEINE; CARBAMAZEPINE; DICLOFENAC; DIETHYLTOLUAMIDE; DRINKING WATER; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTRONE; ETHINYLESTRADIOL; FLUOXETINE; IBUPROFEN; MEPROBAMATE; MUSK KETONE; NAPROXEN; ORGANIC CARBON; PHENYTOIN; PHOSPHORIC ACID TRIS(2 CHLOROETHYL) ESTER; PROGESTERONE; RIVER WATER; STEROID HORMONE; SULFAMETHOXAZOLE; SURFACE WATER; TESTOSTERONE; TRICLOSAN; TRIMETHOPRIM;

CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; ENDOCRINE DISRUPTOR; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; RIVER POLLUTION; SEX HORMONE; SURFACE WATER; TESTOSTERONE; WASTEWATER; WATER POLLUTION; WATER QUALITY;

ARTICLE; BIOCHEMICAL OXYGEN DEMAND; CHEMICAL OXYGEN DEMAND; CONTROLLED STUDY; CORRELATION ANALYSIS; EFFLUENT; ELECTROSPRAY MASS SPECTROMETRY; LIGHT ABSORPTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLLUTANT; PRIORITY JOURNAL; RIVER; SOUTH KOREA; TANDEM MASS SPECTROMETRY; WASTE WATER; WATER POLLUTION; WATER QUALITY; WATER SAMPLING;

CHROMATOGRAPHY, LIQUID; CITIES; COSMETICS; ENDOCRINE DISRUPTORS; HUMANS; PHARMACEUTICAL PREPARATIONS; REPUBLIC OF KOREA; RIVERS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

ASIA; EURASIA; FAR EAST; HAN RIVER [SOUTH KOREA]; KOREA; SOUTH KOREA;

EID: 70749141878     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2009.10.049     Document Type: Article

References (41)

1. Ahrer W., Scherwenk E., and Buchberger W. Determination of drug residues in water by the combination of liquid chromatography or capillary electrophoresis with electrospray mass spectrometry. J Chromatogr A 910 (2001) 69-78
2. APHA- AWWA-WPCF. Standard methods for the examination of water and wastewater. 20th edition (1998) American Public Health Association, Washington D.C
3. Ashton D., Hilton M., and Thomas K.V. Investigating environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333 (2004) 167-184
4. Ayscough N.J., Fawell J., Franklin G., and Young W. Review of human pharmaceuticals in the environment. R&D Technical Report P390 (2000), Environment Agency, Bristol, UK
5. Baronti C., Curini R., D'Ascenzo G., Di Corcia A., Gentili A., and Samperi R. Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water. Environ Sci Technol 34 (2000) 5059-5066
6. Belfroid A.C., Van der Horst A., Vethaak A.D., Schafer A.J., Rijs B.J., Wegener J., et al. Analysis and occurrence of estrogenic hormones and their glucuronides in surface water and wastewater in The Netherlands. Sci Total Environ 225 (1999) 101-108
7. Benotti M.J., Trenholm R.A., Vanderford B.J., Standford B.D., and Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 43 (2009) 597-603
8. Boreen A.L., Arnold W.A., and McNeill K. Photodegradation of pharmaceuticals in the aquatic environment: a review. Aquat Sci 65 (2003) 320-341
9. Boyd R.G., Reemtsma H., Grimm A.D., and Mitra S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Total Environ 311 (2003) 3135-3149
10. Boyd R.G., Palmeri J.M., Zhang S., and Grim D.A. Pharmaceuticals and personal care products (PPCPs) in stormwater canals and Bayou St. John in New Orleans, Louisiana. Sci Total Environ 333 (2004) 137-148
11. Buser H.R., Poiger T., and Muller M.D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33 (1999) 2529-2535
12. Cargouët M., Perdiz D., Mouatassim-Souali A., Tamisier-Karolak S., and Levi Y. Assessment of river contamination by estrogenic compounds in Paris area (France). Sci Total Environ 324 (2004) 55-66
13. Crisp T.M., Clegg E.D., Cooper R.L., Wood W.P., Anderson D.G., Baetcke K.P., et al. Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect 106 (1998) 11-56
14. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 107 (1999) 907-938
15. Fono L.J., and Sedlak D.L. Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ Sci Technol 39 (2005) 9244-9252
16. Fono L.J., Kolodziej E.P., and Sedlak D.L. Attenuation of wastewater-derived contaminants in an effluent-dominated river. Environ Sci Technol 40 (2006) 7257-7262
17. Glassmeyer S.T., Furlong E.T., Cahill J.D., Zaugg S.D., Werner S.L., Meyer M.T., et al. Transport of chemical and microbial compounds from known wastewater discharges: potential for use as indicators of human fecal contamination. Environ Sci Technol 39 (2005) 5157-5169
18. Halling-Sorensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Lutzhoft H.C.H., and Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36 (1998) 357-393 J. Chromatogr, A. 1015, 129-141
19. Heberer T., Reddersen K., and Mechlinski A. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci Technol 46 (2002) 81-88
20. Hilton M.M., and Thomas K.V. Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 1015 (2003) 129-141
21. Jurgens M.D., Holthaus K.I.E., Johnson A.C., Smith J.J.L., Hetheridge M., and Williams R.J. The potential for estradiol and ethinylestradiol degradation in English rivers. Environ Toxicol Chem 21 (2002) 480-488
22. Kim S.D., Cho J., Kim I.S., Vanderford B.J., and Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res 41 (2007) 1013-1021
23. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic waste contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36 (2002) 1202-1211
24. Kolpin D.W., Skopec M., Meyer M.T., and Furlong E.T. Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions. Sci Total Environ 328 (2004) 119-130
25. Lam M.W., Tantuco K., and Mabury S.A. PhotoFate: a new approach in accounting for the contribution of indirect photolysis of pesticides and pharmaceuticals n surface waters. Environ Sci Technol 37 (2003) 899-907
26. Putschew A., Wischnack S., and Jekel M. Occurrence of triiodinated X-ray contrast agents in the aquatic environment. Sci Total Environ 255 (2000) 129-134
27. Richardson M.L., and Bowron J.M. The fate of pharmaceutical chemicals in the environment. J Pharm Pharmacol 37 (1985) 1-12
28. Schittko S., Putschew A., and Jekel M. Bank filtration: a suitable process for the removal of iodinated X-ray contrast media?. Water Sci Technol 50 (2004) 261-268
29. Singer H.P., Tixier C., Oellers S., and Muller S.R. Occurrence and quantification of six widely used pharmaceuticals in surface waters. Poster of work conducted by EAWAG. From: SETAC, challenges in environmental risk assessment and modeling: linking basic and applied research, Vienna, Austria, May (2002)
30. Snyder A.S., Leising J., Westerhoff P., Yoon Y., Mash H., and Vanderford B. Biological and physical attenuation of endocrine disruptors and pharmaceuticals: implications for water reuse. Ground Water Monit Remediat 24 (2004) 108-118
31. Snyder S.A., Keith T.L., Verbrugge D.A., Snyder E.M., Gross T.S., Kannan K., et al. Analytical methods for detection of selected estrogenic compounds in aqueous mixtures. Environ Sci Technol 33 (1999) 2814-2820
32. Snyder S., Wert E., Lei H., Westerhoff P., and Yoon Y. Removal of EDCs and pharmaceuticals in drinking and reuse treatment processes (2007), American Water Works Association Research Foundation
33. Snyder S.A., Westerhoff P., Yoon Y., and Sedlak D.L. Pharmaceuticals, personal care products, and endocrine disruptors in water: implication for the water industry. Environ Eng Sci 20 (2003) 449-469
34. Stackelberg P.E., Furlong E.T., Meyer M.T., Zaugg S.D., Henderson A.K., and Reissman D.B. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci Total Environ 329 (2004) 99-113
35. Stasinakis S.A., Gatidou G., Mamais D., Thomaidis S.N., and Lekkas D.T. Occurrence and fate of endocrine disrupters in Greek sewage treatment plants. Water Res 42 (2008) 1796-1804
36. Stumm-Zollinger E., and Fair G.M. Biodegradation of steroid hormones. J Water Pollut Control Fed 37 (1965) 1506-1510
37. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32 (1998) 3245-3260
38. Trenholm R.A., Vanderford B.J., Holady J.C., Rexing D.J., and Snyder S.A. Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere 65 (2006) 1990-1998
39. Vanderford B.J., Pearson R.A., Rexing D.J., and Snyder S.A. Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal Chem 75 (2003) 6265-6274
40. Vanderford B.J., and Snyder S.A. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ Sci Technol 40 (2006) 7312-7320
41. Westerhoff P., Yoon Y., Snyder S., and Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 39 (2005) 6649-6663